June 2, 2021 | By Bronwen Largier

Business Events Perth has secured two major conferences in the last few days, with thousands of local and international delegates expected to attend the International Congress on Neuromuscular Diseases in Perth in 2024 and Australia’s largest life sciences conference, AusBiotech, heading west in 2022.

The international win was supported by Tourism Australia’s Bid Fund Program.

“This is a tremendous win for Perth and for Australia, and we are thrilled to support business event bids such as this one through our Bid Fund Program,” said Tourism Australia Managing Director Phillipa Harrison.

“The return of the International Congress on Neuromuscular Diseases to Perth in 2024 once again highlights Australia’s expertise in particular knowledge sectors and continued appeal as a world-class business events destination.

“Securing these types of events, particularly with the long lead time involved, will ensure that Australia remains front of mind amongst global decision makers and continues to attract high-value business events in the future,” she said.

Business Events Perth chief executive Gareth Martin said Perth’s business events bidding expertise and the state’s excellence in the neuroscience sector made it the “obvious choice” for the Congress, which was last in Perth over half a century ago.

“As part of the bidding process, Western Australia presented itself as a premium destination to host business events, with a capital city filled with brand-new hotels and venues as well as showing its ingenuity by collaborating with the local organising committee and industry to livestream its presentation to the globally-based decision-making committee,” said Martin.

“This innovation and collaboration meant Western Australia was highly competitive against other global destinations.”

In the nearer future, the domestic AusBiotech is expected to host 1,000 delegates in October 2022 and will be held in conjunction with the Australia Biotech Invest & Partnering event.

“Western Australia’s life science industry is one of the fastest growing in Australia, with the total economic contribution estimated to be $29.7 billion last year,” said Martin.

There are currently around 40 biotechnology and pharmaceutical companies and more than 50 medtech and digital health companies based in Western Australia, along with 22 research institutions and almost 65 services and support organisations.

“The AusBiotech conference and Australia’s leading life sciences investment event [that] will be held in our thriving state is an important opportunity to showcase Western Australia’s significant expertise in the biotech and life sciences sector, not only to the rest of Australia, but also to the world,” said Martin.

“Business events, like conferences, act as a front door for trade and investment, and AusBiotech creates a platform for current and future biotech leaders to pitch their new products to potential investors, creating new opportunities and collaborations, supporting local jobs.”

CEO of AusBiotech, Lorraine Chiroiu said it was the first time the conference would be held in Perth in more than 15 years.

“The mature sector continues to flourish and deliver social and economic benefits to the country, and these platforms offer critical opportunities for industry to engage with each other and with potential investors and partners,” she said.